In 2019, Boris Nikolic, a close friend of Jeffrey Epstein, resigned from the boards of directors and closed his successful venture fund after these ties were made public, leading to a distancing of the biotech industry.[1][2] Nevertheless, one of the most influential venture capitalists in the biotech sector, Alexis Borisy, helped him with his comeback.[1][2] Borisy used his company Curie.Bio to support Nikolic, who raised more than $100 million for his fund in 2024 and 2025.[1] Nikolic has invested in at least one startup company in this fund's portfolio.[1] This information was confirmed by seven sources familiar with the situation.[1] The article also addresses Prasad's departure from the FDA, but details are not specified.[4] The topic is part of The Readout LOUD podcast.[4]